MedPath

OXAYDO

These highlights do not include all the information needed to use OXAYDO safely and effectively. See full prescribing information for OXAYDO. OXAYDO (oxycodone HCl) tablets for oral use only – CII Initial U.S. Approval: 1950

Approved
Approval ID

cff0c64a-63f5-4b3c-909a-cdecf6755cbe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 27, 2023

Manufacturers
FDA

Zyla Life Sciences US LLC

DUNS: 079581441

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

OXYCODONE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69344-213
Application NumberNDA202080
Product Classification
M
Marketing Category
C73594
G
Generic Name
OXYCODONE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateOctober 14, 2020
FDA Product Classification

INGREDIENTS (1)

OXYCODONE HYDROCHLORIDEActive
Quantity: 7.5 mg in 1 1
Code: C1ENJ2TE6C
Classification: ACTIB

OXYCODONE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69344-113
Application NumberNDA202080
Product Classification
M
Marketing Category
C73594
G
Generic Name
OXYCODONE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateOctober 14, 2020
FDA Product Classification

INGREDIENTS (1)

OXYCODONE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: C1ENJ2TE6C
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OXAYDO - FDA Drug Approval Details